Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    NCT01155479
Show Display Options
Rank Status Study
1 Terminated
Has Results
A Placebo- and Active-Controlled Study of Preladenant in Early Parkinson's Disease (PD) (P05664)
Condition: Parkinson Disease
Interventions: Drug: Preladenant 2 mg tablet;   Drug: Preladenant 5 mg tablet;   Drug: Preladenant 10 mg tablet;   Drug: Rasagiline 1 mg capsule;   Drug: Placebo for Rasagiline 1 mg capsule;   Drug: Placebo for Preladenant

Study has passed its completion date and status has not been verified in more than two years.